medicamen organics ipo

Medicamen Organics IPO

  • Status: Closed
  • RHP:
  • ₹ 128,000 / 4000 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    28 Jun 2024

  • Listing Price

    ₹ 137.85

  • Listing Change

    305.44%

  • Last Traded Price

    ₹ 56.30

IPO Details

  • Open Date

    21 Jun 2024

  • Close Date

    25 Jun 2024

  • IPO Price Range

    ₹ 32 to ₹ 34

  • IPO Size

    ₹ 10.54 Cr

  • Listing Exchange

    NSE SME

  • Listing Date

    28 Jun 2024

With just a few clicks, Invest in IPOs!

+91

By proceeding, you agree to all T&C*

hero_form

Medicamen Organics IPO Subscription Status

Last Updated: 05 July 2024 10:33 AM by 5Paisa

Last Updated: 25th June, 2024 by 5paisa

Medicamen Organics IPO is all set to open from 21st June to 25th June 2024. The company develops, manufactures, and distributes a wide range of pharmaceutical products. The IPO includes a fresh issue of 3,100,000 shares worth ₹10.54 cr. The share allotment date is 26th June 2024, and the IPO will be listed on 28th June 2024 on the stock exchanges. The price band is ₹32 to ₹34 and the lot size is 4000 shares.    

GYR Capital Advisors Private Limited is the book-running lead manager for this IPO, while   Kfin Technologies Limited is the registrar. 

Objectives of Medicamen Organics IPO

Medicamen Organics Limited plans to utilize the raised capital from the IPO to:

●    To fund the working capital requirement.
●    To fund the working expenditure requirement for Product registration in the international markets.
●    To update the plant and increase the production capacity.
●    General corporate purposes.

Medicamen Organics develops, manufactures, and distributes a wide range of pharmaceutical products. This includes generic dosage in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company undertakes the production for state and central government as well as for private institutions as a contract manufacturer / third-party manufacturer. 

The company’s products are marketed in India as well as African, CIS and South East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by its third-party distributor. The company is planning to increase its global presence and has directly exported products to Burundi.

The company’s product line has 84 products which include drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS). It has 2 manufacturing units based in Haridwar, Uttarakhand which are WHO GMP-approved. It also has an ISO 9001:2015 certification.

Peer Comparison

●    Brooks Laboratories Limited
●    Cian Healthcare Limited
●    Zenotech Laboratories Limited

For More Information:
Webstory on Medicamen Organics IPO

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY24 FY23 FY22
Revenue from operations 25.27 22.14 20.97
EBITDA 4.75 2.68 1.40
PAT 2.40 0.96 0.10
Particulars (in Rs. Crores) FY24 FY23 FY22
Total Assets 38.58 32.58 27.53
Share Capital 8.60 6.00 6.00
Total Borrowings 23.39 23.60 19.52
Particulars (in Rs. Crores) FY24 FY23 FY22
Net cash generated from / (used in) operating activities -3.68 -0.58 0.037
Net cash from / (used in) investing activities -0.33 -0.28 -0.59
Net cash flow from / (used in) financing activities 4.01 0.93 0.18
Net increase (decrease) in cash and cash equivalents -0.0074 0.071 -0.37


Strengths

1.    The company manufactures a wide range of products.
2.    Its business model is customer-centric and order-driven.
3.    It focuses on high quality and is certified.
4.    Experienced promoters and management team.
 

Risks

1.    The company needs several approvals, licenses, registrations and permits to run the business. 
2.    It is subject to risks associated with expansion into new markets.
3.    It is also subject to foreign currency exchange rate fluctuations.
4.    It has reported negative cash flow in the past. 
5.    It operates in a competitive environment.
6.    High working capital requirements. 
 

Will You Apply for Medicamen Organics IPO?

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

FAQs

Medicamen Organics IPO opens from 21st June to 25th June 2024.
 

The size of Medicamen Organics IPO is ₹10.54 cr. 
 

To apply for Medicamen Organics IPO, follow the steps given below:

●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for Medicamen Organics IPO.  
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    

You will receive a mandate notification to block funds in your UPI app.
 

The price band of Medicamen Organics IPO is fixed at ₹32 to ₹34 per share. 
 

The minimum lot size of Medicamen Organics IPO is 4000 shares and the investment required is ₹1,28,000.
 

The share allotment date of Medicamen Organics IPO is 26th June 2024.
 

The Medicamen Organics IPO will be listed on 28th June 2024.
 

GYR Capital Advisors Private Limited is the book-running lead manager for Medicamen Organics IPO.
 

Medicamen Organics plans to utilize the raised capital from the IPO to:

●    To fund the working capital requirement.
●    To fund the working expenditure requirement for Product registration in the international markets.
●    To update the plant and increase the production capacity.
●    General corporate purposes.